[Upadacitinib (psoriatic arthritis) - Addendum to Commission A21-15]
Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen
Record ID 32018003904
German
Original Title:
Upadacitinib (Psoriasis-Arthritis) - Addendum zum Auftrag A21-15
Details
Project Status:
Completed
URL for project:
https://www.iqwig.de/projekte/a21-81.html
Year Published:
2021
URL for published report:
https://www.iqwig.de/download/a21-81_upadacitinib_addendum-zum-auftrag-a21-15_v1-0.pdf
English language abstract:
There is no English language summary available
Publication Type:
Full HTA
Country:
Germany
MeSH Terms
- Arthritis, Psoriatic
- Antirheumatic Agents
- Janus Kinase Inhibitors
Keywords
- Upadacitinib
- Arthritis - Psoriatic
- Benefit Assessment
- NCT03104400
Contact
Organisation Name:
Institute for Quality and Efficiency in Health Care (IQWiG)
Contact Address:
IQWiG, Im Mediapark, 8, DE-50670 Cologne, GERMANY, Tel: +49(0)221-35685, Fax: +49(0)221-356851
Contact Email:
berichte@iqwig.de
Copyright:
Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.